A Calcineurin Inhibitor as an Enhancer of <i>Candida</i> Susceptibility to Anidulafungin. [PDF]
ACS OmegaRovira I +7 more
europepmc +1 more source
Micafungin microevolution in <i>Candida auris</i> reveals resistance development without <i>in vivo</i> fitness compromise. [PDF]
VirulenceBohner F +5 more
europepmc +1 more source
Deciphering the multidrug resistance paradigm in <i>Candida auris</i>. [PDF]
Antimicrob Agents ChemotherSantana DJ +3 more
europepmc +1 more source
Antifungal efficacy of linoleic-acid-rich Cucurbita pepo L. seed oil revealed by GC-MS profiling of lipids and bioactive markers, ergosterol depletion, and network pharmacology. [PDF]
BMC MicrobiolMohamed ET.
europepmc +1 more source
Recent Outbreaks, Resistance Trends, and Control Measures in <i>Candida auris</i> and <i>Candida glabrata</i> Infections. [PDF]
J Fungi (Basel)Raeisi S, Madhavan P, Adisuri DS.
europepmc +1 more source
SCY-247, a novel second-generation triterpenoid antifungal, demonstrates high in vitro activity against genetically diverse Candida auris isolates, including FKS1 mutants. [PDF]
J Antimicrob ChemotherSpruijtenburg B, de Groot T, Meijer EFJ.
europepmc +1 more source
A Candidozyma (Candida) auris-Optimized Episomal Plasmid-Induced Cas9-Editing System Reveals the Direct Impact of the S639F-Encoding FKS1 Mutation. [PDF]
J Infect DisDoorley LA +3 more
europepmc +1 more source
Experimental Evolution of Pathogenic <i>Candida</i> spp.: Insights into Adaptive Processes and Evolutionary Dynamics. [PDF]
MicroorganismsSousa G, Correia I, Bezerra AR.
europepmc +1 more source
<i>Candidozyma auris</i> susceptibility from Michigan hospitals to manogepix, rezafungin and nine other antifungal agents. [PDF]
JAC Antimicrob ResistKlamer KS +4 more
europepmc +1 more source
The Upcoming Antifungal Drugs in Clinical Development for the Treatment of Invasive Candidiasis. [PDF]
Infect Drug ResistZubovskaia A, Vazquez JA.
europepmc +1 more source